Ayman Yosry

3.8k total citations
60 papers, 782 citations indexed

About

Ayman Yosry is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Ayman Yosry has authored 60 papers receiving a total of 782 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Epidemiology, 39 papers in Hepatology and 7 papers in Surgery. Recurrent topics in Ayman Yosry's work include Liver Disease Diagnosis and Treatment (41 papers), Hepatitis C virus research (25 papers) and Liver Disease and Transplantation (19 papers). Ayman Yosry is often cited by papers focused on Liver Disease Diagnosis and Treatment (41 papers), Hepatitis C virus research (25 papers) and Liver Disease and Transplantation (19 papers). Ayman Yosry collaborates with scholars based in Egypt, United States and Iraq. Ayman Yosry's co-authors include Gamal Esmat, Naglaa Zayed, Imam Waked, Manal H. El‐Sayed, Rabab Fouad, Gamal Shiha, Aisha Elsharkawy, Homie Razavi, Chris Estes and Wahid Doss and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Hepatology and Surgical Endoscopy.

In The Last Decade

Ayman Yosry

53 papers receiving 756 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ayman Yosry Egypt 15 500 467 113 99 80 60 782
Mahmoud El‐Bendary Egypt 17 282 0.6× 264 0.6× 98 0.9× 95 1.0× 46 0.6× 62 629
Aisha Elsharkawy Egypt 17 668 1.3× 670 1.4× 47 0.4× 72 0.7× 57 0.7× 62 862
Luiz Guilherme Costa Lyra Brazil 17 403 0.8× 448 1.0× 128 1.1× 51 0.5× 18 0.2× 38 704
Nyingi Kemmer United States 20 649 1.3× 791 1.7× 390 3.5× 46 0.5× 43 0.5× 65 1.1k
Fu‐Hsiung Su Taiwan 18 528 1.1× 431 0.9× 53 0.5× 54 0.5× 23 0.3× 39 833
Yasuhiro Takikawa Japan 15 315 0.6× 582 1.2× 129 1.1× 46 0.5× 27 0.3× 66 861
Jiaji Jiang China 20 963 1.9× 895 1.9× 85 0.8× 151 1.5× 82 1.0× 56 1.2k
Mohamed Abdel-Hamid Egypt 12 492 1.0× 563 1.2× 83 0.7× 39 0.4× 24 0.3× 20 865
Ramou Njie Gambia 14 693 1.4× 632 1.4× 67 0.6× 47 0.5× 54 0.7× 26 870
Fadi Antaki United States 14 200 0.4× 128 0.3× 199 1.8× 76 0.8× 30 0.4× 47 581

Countries citing papers authored by Ayman Yosry

Since Specialization
Citations

This map shows the geographic impact of Ayman Yosry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayman Yosry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayman Yosry more than expected).

Fields of papers citing papers by Ayman Yosry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayman Yosry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayman Yosry. The network helps show where Ayman Yosry may publish in the future.

Co-authorship network of co-authors of Ayman Yosry

This figure shows the co-authorship network connecting the top 25 collaborators of Ayman Yosry. A scholar is included among the top collaborators of Ayman Yosry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayman Yosry. Ayman Yosry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Alem, Shereen Abdel, et al.. (2023). The Interrelation Between Hypothyroidism and Non-alcoholic Fatty Liver Disease, a Cross-sectional Study. Journal of Clinical and Experimental Hepatology. 13(4). 638–648. 7 indexed citations
3.
Elrahman, Mohamed Abd, Ahmed Khairy, Ayman Yosry, et al.. (2023). The Impact of interferon lambda 3 Polymorphism on Hepato-Cellular Carcinoma Progression in Hepatitis C Virus Patients: Treatment-Naïve and Experienced. Asian Pacific Journal of Cancer Prevention. 24(1). 215–221. 2 indexed citations
4.
Adel, Heba, et al.. (2023). Clinical Significance of Evaluation of Monocytic Receptors in Patients with Hepatitis C Virus Infection. Viral Immunology. 36(7). 475–483. 1 indexed citations
5.
Yosry, Ayman, Naglaa Zayed, Reham M. Dawood, et al.. (2022). Highly Sensitive Serum miRNA Panel for the Diagnosis of Hepatocellular Carcinoma in Egyptian Patients with HCV-Related HCC. Laboratory Medicine. 53(5). 523–529. 6 indexed citations
6.
Okasha, Hussein, et al.. (2022). The Role of Interleukin 1 Beta in Differentiating Malignant from Benign Pancreatic Cysts. Journal of Interferon & Cytokine Research. 42(3). 118–126. 2 indexed citations
7.
Dawood, Reham M., Hend Ibrahim Shousha, Mohamed Nabil, et al.. (2022). Seven gene signature explores the impact of DAAs on the appearance of hepatocellular carcinoma in HCV infected patients. Heliyon. 8(8). e10119–e10119. 2 indexed citations
8.
El‐Kassas, Mohamed, Wafaa Elakel, Mohamed Alboraie, et al.. (2022). Egyptian revalidation of non-invasive parameters for predicting esophageal varices in cirrhotic patients: A retrospective study. Arab Journal of Gastroenterology. 23(2). 120–124.
9.
Elshaarawy, Omar, et al.. (2022). Acoustic radiation force impulse to measure liver stiffness and predict hepatic decompensation in pregnancy with cirrhosis: A cohort study. Arab Journal of Gastroenterology. 23(2). 89–94. 1 indexed citations
10.
Dawood, Reham M., Ghada M. Salum, Ayman Yosry, et al.. (2021). Development of a gene signature for predicting cirrhosis risk score of chronic liver disease associated with HCV infection in Egyptians. Microbial Pathogenesis. 153. 104805–104805. 5 indexed citations
11.
12.
Yosry, Ayman, Eman Medhat, Naglaa Zayed, et al.. (2018). Efficacy and safety of sofosbuvir‐based therapy in hepatitis C virus recurrence post living donor liver transplant: A real life egyptian experience. Journal of Medical Virology. 91(4). 668–676. 2 indexed citations
13.
14.
15.
16.
Elbaz, Tamer, Magdy El‐Serafy, Wafaa Elakel, et al.. (2017). Serious Adverse Events with Sofosbuvir Combined with Interferon and Ribavirin: Real-Life Egyptian Experience. Journal of Interferon & Cytokine Research. 37(8). 348–353. 4 indexed citations
17.
18.
Khairy, Ahmed, et al.. (2016). Serum miRNA Panel in Egyptian Patients with Chronic Hepatitis C Related Hepatocellular Carcinoma.. PubMed. 17(5). 2699–703. 18 indexed citations
19.
Yosry, Ayman, et al.. (2013). Transient Elastography can Predict the Risk of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C. Journal of Gastroenterology and Hepatology Research. 2(7). 687–691.
20.
Yosry, Ayman, et al.. (2011). The association of HLA class II DR B1 alleles with HCV infection in Egyptian children. Arab Journal of Gastroenterology. 12(1). 25–28. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mahmoud El‐Bendary Breakdown of academic impact, for papers by Aisha Elsharkawy Breakdown of academic impact, for papers by Luiz Guilherme Costa Lyra Breakdown of academic impact, for papers by Nyingi Kemmer Breakdown of academic impact, for papers by Fu‐Hsiung Su Breakdown of academic impact, for papers by Yasuhiro Takikawa Breakdown of academic impact, for papers by Jiaji Jiang Breakdown of academic impact, for papers by Mohamed Abdel-Hamid Breakdown of academic impact, for papers by Ramou Njie Breakdown of academic impact, for papers by Fadi Antaki
Rankless by CCL
2026